log in
Print | Back

Walder Wyss Ltd.

Jessica Aeschbach Flórez

Jessica Aeschbach Flórez

Senior Associate

Profile
Jessica Aeschbach Flórez is Attorney at Law in the Basel office of Walder Wyss. She advises clients on matters of commercial and corporate law, M&A as well as contract and labour law.

Born in 1983, Jessica Aeschbach Flórez studied at the University of Fribourg (BLaw 2005, MLaw 2006), where she obtained in 2012 the doctorate degree (Peter Jäggi Foundation Award 2011/2012, Professor Walther Hug Award 2013) and worked as a research and teaching assistant of Prof. Franz Werro and Prof. Walter A. Stoffel (2006-2010). Jessica Aeschbach Flórez was admitted to the bar in 2012, after having worked as a trainee lawyer at a leading law firm in Basel and at the Civil Court of Basel-City. Before joining Walder Wyss, Jessica Aeschbach Flórez worked as Attorney at Law in the tax team of a leading law firm in Zurich (2013-2015).

Jessica Aeschbach"s professional languages are German, English and French. She is registered with the bar registry of the canton of Basel-Stadt.
Areas of Practice

Corporate & Commercial | Employment | Healthcare & Life Sciences | Industry & Commerce | Mergers & Acquisitions | Private Clients

Professional Career

Significant Accomplishments


Alentis Therapeutics erhält USD 67 Mio. im Rahmen einer Serie-B-Finanzierung

proLogistik Holding GmbH erwirbt XELOG AG

Boehringer Ingelheim kauft NBE-Therapeutics für EUR 1,18 Milliarden

BioVersys Serie B-Finanzierungsrunde über CHF 19 Mio.

Versant Ventures lanciert Matterhorn Biosciences

Versant Ventures bringt Bright Peak Therapeutics auf den Markt

ImmunOs Therapeutics AG raises CHF 15m in Series A Financing

Lindsay Goldberg übernimmt Bilcare Research Group

Cellestia Biotech AG: CHF 20 Millionen Series A Finanzierungsrunde

TOLREMO Therapeutics AG CHF 9 Mio. Serie A Finanzierungsrunde

Nouscom AG EUR 42 Mio. Serie B Finanzierungsrunde

Acino veräussert sein Geschäft mit transdermalen Pflastern an Luye Pharma Group Ltd.


Articles


Obligatorische Umwandlung von Inhaberaktien in Namensaktien zum 1. Mai 2021


WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021